Geron Corporation
Ticker(s):
GERNW and GERN
Country:
Sector & Industry:
Business Overview
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia. The company was incorporated in 1990 and is headquartered in Foster City, California.
Contact & Other Information
Number of Employees:
229
Website:
919 East Hillsdale Boulevard
Suite 250
Foster City
,
CA
,
94404
United States
650 473 7700
No content was found.